Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $18.32 -0.34 (-1.82%) As of 04/25/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1SLNOSoleno Therapeutics$73.26-1.3%1.78%2,4292SMMTSummit Therapeutics$23.47-36.0%1.69%6,3003ANABAnaptysBio$20.70+0.4%1.65%7,4904AKROAkero Therapeutics$41.00+0.0%1.56%3,8775LQDALiquidia$14.12+0.6%1.45%10,2216XERSXeris Biopharma$4.31+0.7%1.42%33,0867PTGXProtagonist Therapeutics$44.49-0.8%1.36%2,7868ARQTArcutis Biotherapeutics$14.61-0.7%1.32%9,1879MLYSMineralys Therapeutics$13.34-5.3%1.30%9,24910Bny Mellon Cash Reserve UsdN/A1.25%117,294 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11MRUSMerus$43.57-1.8%1.25%2,71912CVACCureVac$3.23-0.9%1.20%35,15113ZYMEZymeworks$12.57+0.4%1.12%8,91714SVRASavara$3.18-2.8%1.09%33,58015ABUSArbutus Biopharma$3.29-1.5%1.08%31,59516SNDXSyndax Pharmaceuticals$13.33+0.2%1.06%8,35617QUREuniQure$14.18-0.6%1.06%7,47518XENEXenon Pharmaceuticals$37.62-1.5%1.05%2,85219DNTHDianthus Therapeutics$21.67+2.1%1.04%4,78820BLTEBelite Bio$58.23-2.3%1.03%1,77521RNAAvidity Biosciences$30.84-0.3%1.01%3,33122ABCLAbCellera Biologics$2.57-1.2%1.00%38,13223CAPRCapricor Therapeutics$13.03-1.9%1.00%7,84724ITOSiTeos Therapeutics$7.35-1.5%1.00%14,15825CELCCelcuity$10.80-2.2%0.99%8,92626RVMDRevolution Medicines$38.77+0.5%0.98%2,50327MNMDMind Medicine (MindMed)$6.23-3.1%0.97%16,02328NUVLNuvalent$73.48-0.7%0.97%1,29629ETNB89bio$6.94+0.6%0.96%14,32830OMEROmeros$7.31+0.1%0.95%13,25531LENZLENZ Therapeutics$26.87-6.1%0.94%3,65532KROSKeros Therapeutics$14.21-1.5%0.93%6,10633RXRXRecursion Pharmaceuticals$5.73-0.3%0.93%16,11434SANASana Biotechnology$1.770.93%55,14235CMPSCOMPASS Pathways$3.82-4.3%0.92%25,51436RGNXREGENXBIO$9.15-0.5%0.92%12,90737VERVVerve Therapeutics$5.76-0.3%0.92%18,05638AVBPArriVent BioPharma$20.82-1.7%0.91%4,34939CYTKCytokinetics$40.43+0.2%0.91%2,24240PHVSPharvaris$16.84+6.4%0.91%5,919Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.41NUVBNuvation Bio$2.130.90%42,77542VIRVir Biotechnology$6.12-2.7%0.90%15,13943APGEApogee Therapeutics$36.85-0.5%0.89%2,53744EYPTEyePoint Pharmaceuticals$6.37-2.6%0.89%14,16545MLTXMoonLake Immunotherapeutics$39.42-0.1%0.89%2,09146TRMLTourmaline Bio$16.89-2.5%0.89%4,99847ACLXArcellx$63.71-0.4%0.88%1,34848VRDNViridian Therapeutics$13.50-0.4%0.88%6,25849GPCRStructure Therapeutics$23.74+0.4%0.87%3,54850CNTACentessa Pharmaceuticals$13.79+1.3%0.86%6,673 Geographic ExposureUnited States87.6%Canada3.1%Netherlands2.6%Cayman Islands0.8%Ireland0.8%Virgin Islands, British0.6%Singapore0.5%Currency ExposureUSD100.0%Sector ExposureHealth Care95.7%Energy1.2%Consumer Discretionary0.7%Industry ExposureBiotechnology84.4%Pharmaceuticals10.4%Diversified Consumer Services1.6%Renewable Energy1.2%SubIndustry ExposureBiotechnology80.4%Pharmaceuticals11.9%Renewable Energy Equipment1.2%Coupon Exposure0-20.8% Related Companies and Tools Related Companies PILL Portfolio JDOC Portfolio FTXH Portfolio MEDI Portfolio MEDX Portfolio BIS Portfolio LGHT Portfolio HYLG Portfolio RXD Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
